Cameron Findlater

Healthcare Analyst at @Datamonitor_HC. Views expressed are my own.

[Jack Allen @JohnK_Allen]

New episode of DMHC analyst podcast:
-Tecentriq $RHHBY meets primary endpoint in IMpassion130 trial for TNBC $MRK $AZN-0:31
-Top-line results from the INDIGO trial of gemcabene $GEMP-10:54
-CGRP market overview $AMGN $LLY $TEVA $ALDR $BHVN $AGN-19:36
https://t.co/1Cbotrv65b

[Jack Allen @JohnK_Allen]

New podcast:
-Analysis of volanesorsen $AKCA $IONS advisory committee meeting-:28
-Approval of AndexXa $PTLA for reversal of Eliquis $BMY $PFE and Xarelto $BAYR-8:13
- $LLY announces acquisition of $ARMO-17:5

Please RT or comment if you find this useful

https://t.co/KoM3iivkzO

[Jack Allen @JohnK_Allen]

New podcast on recent events:
-Allogene in-licenses TALEN (originally by $CLLS) technology from $PFE-0:30
-Data for NeuVax $SLS/Herceptin $RHHBY combination in breast cancer-10:45
-Early termination of Phase 2 trial of MN-001 $MNOV in NASH/NAFLD-17:40
https://t.co/1s8HmyiLnG

[Jack Allen @JohnK_Allen]

New analyst podcast reviewing key #ASH17 abstracts:
- Results from bluebird bio’s anti-BCMA CAR T $BLUE $CELG $JUNO $GILD-0:43
- 6-month results from the JULIET trial $NVS $GILD $JUNO-8:36
- Results from Imbruvica+Venclexta in CLL $ABBV $RHHBY-19:56

https://t.co/4ndHUye6Ng

[Cameron Findlater @Datamonitor_CF]

Podcast #ASH17 abstract reviews- $CLLS-:35; $JUNO-12:20; $BLUE-26:13; CDK-4/6 sales $PFE $NVS $LLY-22:15

https://t.co/PbMzn9O3ly

[CDC HIV @CDC_HIV]

Today is National HIV/AIDS & Aging Awareness Day. With diagnosis & treatment, most people with #HIV can live long, healthy lives. #NHAAAD

[Cameron Findlater @Datamonitor_CF]

First mobile app to treat substance use in conjunction with outpatient therapy approved by FDA. https://t.co/Rv67HxmnTL